publication venue for
- Editorial: Global excellence in inflammatory diseases: Latin America 2021 2023
- Editorial: Innate lymphoid cell development, migration, and function 2023
- Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system 2023
- Immune system modulation in aging: Molecular mechanisms and therapeutic targets. 13. 2022
- Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus. 13. 2022
- Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?. 13. 2022
- Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297). 12. 2021
- Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). 12. 2021
- Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens. 12. 2021
- CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome. 12. 2021
- Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation. 11. 2021
- Evolutionary Pattern of Interferon Alpha Genes in Bovidae and Genetic Diversity of IFNAA in the Bovine Genome. 11. 2020
- Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells. 11. 2020
- Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation. 11. 2020
- Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis. 11. 2020
- Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis. 10. 2019